Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;33(4):e13528.
doi: 10.1111/dth.13528. Epub 2020 May 22.

Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review

Affiliations
Review

Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review

Keyun Tang et al. Dermatol Ther. 2020 Jul.

Abstract

COVID-19, first appeared in December 2019 in Wuhan, China, has been spreading quickly throughout the world. We reviewed the evidence on cutaneous manifestations of COVID-19 based on PubMed database. The searching strategy was (COVID* or coronavirus*) and (dermatol* or skin* or cutaneous*). The publication time was limited to 2019 onward. After independent review by two authors, 14 studies with 228 confirmed cases were included in the analysis. A total of 60 patients developed skin rashes, and the age ranged from 8 to 84. Exanthematous eruptions potentially related to COVID-19 infection were highly variable and heterogeneous. Skin lesions mainly appeared erythematous, urticarial, and vesicular (chicken pox-like or varicelliform). Petechiae rash, livedo reticularis, and reactivation of oral HSV-1 were also observed in single cases. Newly reported eruptions like vascular lesions and peculiar (perniosis-like) skin lesions caused concern among dermatologists. Exanthems were widely distributed and were primarily located on the trunk. Associated symptoms, latency time, treatment, and prognosis were also carefully summarized. This study reviewed the recently published COVID-19 studies with skin manifestations, which may pave the way for further research.

Keywords: COVID-19; coronavirus; cutaneous manifestations; review; skin.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

References

    1. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID‐19 infection. J Eur Acad Dermatol Venereol: JEADV. 2020. 10.1111/jdv.16472 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave‐Roblot F, Masson Regnault M. Comment on "cutaneous manifestations in COVID‐19: a first perspective " by Recalcati S. J Eur Acad Dermatol Venereol. 2020. 10.1111/jdv.16519 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol: JEADV. 2020. 10.1111/jdv.16387 [Epub ahead of print]. - DOI - PubMed
    1. Alramthan A, Aldaraji W. A Case of COVID‐19 Presenting in Clinical Picture Resembling Chilblains Disease. First report from the Middle East. Clin Exp Dermatol. 2020. 10.1111/ced.14243 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Estebanez A, Perez‐Santiago L, Silva E, et al. Cutaneous manifestations in COVID‐19: a new contribution. J Eur Acad Dermatol Venereol: JEADV. 2020. 10.1111/jdv.16474 [Epub ahead of print]. - DOI - PMC - PubMed